Phorm shares rise after trial success announcement

LONDON - Shares in Phorm have leapt more than 50 per cent to 305p, following the announcement that it would roll out its controversial technology next year.

Phorm...share rise leapt
Phorm...share rise leapt

Phorm announced yesterday that it had completed a trial with BT that had successfully tested the technology.

Before the announcement, the company's share price was 200p, after which it rose to 305p today.

Phorm is behind technology that analyses web users' behaviour in a bid to serve up more relevant advertising.

The company has been criticised because of fears that its technology will allow internet companies to spy on users.

Become a member of Campaign

Get the very latest news and insight from Campaign with unrestricted access to, plus get exclusive discounts to Campaign events.

Become a member

What is Campaign AI?

Our new premium service offering bespoke monitoring reports for your company.

Find out more

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an alert now

Partner content